within Pharmacolibrary.Drugs.ATC.B;

model B05CA01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.02,
    Cl             = 0.16666666666666666,
    adminDuration  = 600,
    adminMass      = 0.002,
    adminCount     = 1,
    Vd             = 0.05,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0016666666666666668,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Cetylpyridinium is a quaternary ammonium compound with antiseptic properties, commonly used as a cationic surfactant and disinfectant. It is mainly used in oral care products such as mouthwashes and lozenges for its antibacterial activity against Gram-positive bacteria. Cetylpyridinium is not typically used systemically and lacks clinical approval for systemic therapeutic indications. It remains an approved agent in oral hygiene.</p><h4>Pharmacokinetics</h4><p>No published data available for human systemic pharmacokinetics. Systemic exposure is negligible due to local use and minimal absorption. Parameters are estimated based on physicochemical profile and assumptions.</p><h4>References</h4><ol><li><p>Darsazan, B, et al., &amp; Mortazavi, SA (2018). Evaluation of Ion-pair Formation of Adefovir to Improve Permeation across Artificial and Biological Membranes. <i>Journal of pharmacy &amp; pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques</i> 21(1) 160–170. DOI:<a href=&quot;https://doi.org/10.18433/jpps29394&quot;>10.18433/jpps29394</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29789103/&quot;>https://pubmed.ncbi.nlm.nih.gov/29789103</a></p></li><li><p>Matsuo, K, et al., &amp; Van Meerbeek, B (2019). Rechargeable anti-microbial adhesive formulation containing cetylpyridinium chloride montmorillonite. <i>Acta biomaterialia</i> 100 388–397. DOI:<a href=&quot;https://doi.org/10.1016/j.actbio.2019.09.045&quot;>10.1016/j.actbio.2019.09.045</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31568874/&quot;>https://pubmed.ncbi.nlm.nih.gov/31568874</a></p></li><li><p>García-Godoy, F (2005). Advances in therapeutic mouthrinses. <i>American journal of dentistry</i> 18 Spec No 2A–None. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/16178128/&quot;>https://pubmed.ncbi.nlm.nih.gov/16178128</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end B05CA01;
